Oncological Benefits of Neoadjuvant Chemoradiation With Gemcitabine Versus Upfront Surgery in Patients With Borderline Resectable Pancreatic Cancer: A Prospective, Randomized, Open-label, Multicenter Phase 2/3 Trial
2018
- Correction
- Cite
- Save
- Machine Reading By IdeaReader
0
References
25
Citations
NaN
KQI